GLIACURE, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.gliacure.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2016-02-03
- Lead Sponsor
- GliaCure, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT02386306
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Long Beach, California, United States
🇺🇸Quantum laboratories / Memory Disorder Center, Deerfield Beach, Florida, United States
🇺🇸MD Clinical, Hallandale Beach, Florida, United States
Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- GliaCure, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT02254369
- Locations
- 🇺🇸
Celerion, Neptune, New Jersey, United States
News
No news found